Vivos Therapeutics, Inc. 8-K

What Happened Vivos Therapeutics, Inc. (VVOS) filed an 8-K on June 16, 2026 disclosing that on June 10, 2026 it entered a Collaboration Agreement with South Palm Cardiovascular Associates, LLC (SPCVA) to create a new management services organization called AIM Florida. AIM Florida is intended to provide administrative, operational, billing, payer-contracting, marketing, platform, data and other non‑clinical support to affiliated clinical entities delivering sleep apnea diagnostic and treatment services, initially focused on Palm Beach County, Florida. Vivos expects to hold not less than 80% of AIM Florida’s membership interests; SPCVA expects to hold up to 20%.

Key Details

• Agreement date: June 10, 2026; Form 8‑K filed June 16, 2026.
• New entity: AIM Florida, LLC — a management services organization for sleep apnea services.
• Ownership: Vivos expects ≥80% membership interest; SPCVA up to 20%, subject to definitive documentation and regulatory approvals.
• Governance & operations: Vivos’ wholly owned subsidiary, Vivos Provider Network, LLC, is contemplated to be the initial manager. SPCVA’s investment will be at fair market value; cash distributions and income/loss allocations will be proportional to membership percentages.

Why It Matters This agreement creates a centralized management services entity intended to support clinical providers of sleep apnea diagnostics and treatment in the Palm Beach County market. For investors, material points are Vivos’ expected controlling stake (≥80%) and that the company’s provider-network subsidiary is to manage AIM Florida — indicating operational control of the new venture. The filing also notes SPCVA’s investment terms and proportional distribution mechanics, which define economic rights between the parties. A company press release about the collaboration was furnished as Exhibit 99.1 to the 8‑K.